CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells

類似資料

• Synergistic Inhibition of R5 HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Implications for Treatment and Prevention
  著者:: LATINOVIC, OLGA, 等
  出版事項: (2011)
• Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc
  著者:: Latinovic, Olga, 等
  出版事項: (2009)
• Binding of fusion protein FLSC IgG1 to CCR5 is enhanced by CCR5 antagonist Maraviroc
  著者:: Latinovic, Olga, 等
  出版事項: (2014)
• CCR5 Inhibitors and HIV-1 Infection
  著者:: Latinovic, Olga S., 等
  出版事項: (2019)
• Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
  著者:: Heredia, Alonso, 等
  出版事項: (2008)